Long-term response to interferon alpha is unrelated to 'interferon sensitivity determining region' variability in patients with chronic hepatitis C virus-1b infection

Journal of Hepatology

Volumn 30, Issue 6, 1999, Pages 1023-1027

  Squadrito, Giovanni ^a   Orlando, Maria Elena ^a   Cacciola, Irene ^a   Rumi, Maria Grazia ^b   Artini, Marco ^c   Picciotto, Antonio ^d   Loiacono, Oreste ^e   Siciliano, Rocco ^f   Levrero, Massimo ^c   Raimondo, Giovanni ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF PALERMO   (Italy)

^f UNIVERSITY OF CATANIA   (Italy)

Author keywords

Chronic hepatitis C; Direct sequencing; Non structural 5A protein; Polymerasae chain reaction; Vital genomic heterogeneity

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; GENE AMPLIFICATION; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; VIRUS GENOME;

EID: 0033032032     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80255-4     Document Type: Article

References (19)

1. Hoofnagle JH. Therapy of acute and chronic viral hepatitis 1994. Adv Intern Med. 39:1994;241-275.
2. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, et al. Pretreatment serum HCV RNA levels and HCV genotype are the main and independent prognostic factors of sustained response to alpha interferon therapy in chronic hepatitis C. Hepatology. 22:1995;1050-1056.
3. Manesis EK, Papaioannou C, Gioustozi A, Kafiri G, Koskinas J, Hadziyannis S. Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients. Hepatology. 26:1997;734-739.
4. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b - sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Inves. 96:1995;224-230.
5. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b interferon. N Engl J Med. 334:1996;77-81.
6. Kurosaky M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, et al. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to response to interferon-β therapy. Hepatology. 25:1997;750-753.
7. Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, et al. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology. 25:1997;745-749.
8. Sàiz J-C, Lòpez-Labrador F-X, Ampurdanès S, Dopazo J, Forns X, Sànchez-Tapìas J-M, et al. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determing region is different in infections with genotype 1b and 3a isolates of hepatitis C virus. J Infect Dis. 177:1997;839-847.
9. Khorsi H, Castelain S, Wyseur A, Izopet J, Canva A, Rombout D, et al. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon alfa therapy in French patients. J Hepatol. 27:1997;72-77.
10. Zeuzem S, Lee J-H, Roth WK. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology. 25:1997;740-744.
11. Squadrito G, Leone F, Sartori M, Nalpas B, Berthelot P, Raimondo G, et al. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology. 113:1997;567-572.
12. Hofgartner W, Polyak SJ, Sullivan D, Carithers RL Jr., Gretch DR. Mutations in the NS5A gene of hepatitis C virus in north american patients infected with HCV genotype 1a or 1b. J Med Virol. 53:1997;118.
13. Pawlotsky J-M, Germanidis G, Neumann AU, Pellerin M, Frainais P-O, Dhumeaux D. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol. 72:1998;2795-2805.
14. De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, et al. A classification of chronic hepatitis. Lancet. ii:1968;626-628.
15. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.
16. Kato N, Hijikata M, Oostuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA. 87:1990;9524-9528.
17. Gale MJ, Korth MJ, Tang SL, Hopkins DA, Dever TE, Polyak SJ, et al. Evidence that hepatitis C virus resistence to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology. 230:1997;217-227.
18. Gale MJ, Blakely CM, Kwieciszewski B, Tang SL, Dosset M, Tang N, et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol. 18:1998;2431-2443.
19. Duverlie G, Khorsi H, Castelain S, Jaillon O, Izopet J, Lunel F, et al. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. J Gen Virol. 79:1998;1373-1381.